Mycophenolate Mofetil as First-Line Therapy for Ocular Myasthenia Gravis

Identifier 20110208_nanos_posters_104
Title Mycophenolate Mofetil as First-Line Therapy for Ocular Myasthenia Gravis
Creator Lindsey De Lott; Aileen Antonio-Santos; Eric Eggenberger; Preston Calvert; Wayne Cornblath
Affiliation (LD) (WC) University of Michigan, Ann Arbor, MI, United States; (AA) (EE) Michigan State University, East Lansing, MI; (PC) Alexandria, VA
Subject Myasthenia; Mycophenolate
Description Ocular myasthenia gravis (OMG) may produce debilitating diplopia or ptosis leading to significant visual disability. Symptomatic treatment with pyridostigmine is frequently ineffective and immunosuppressive therapy with corticosteroids can have serious side-effects.
Date 2011-02-08
Language eng
Format application/pdf
Type Text
Source 2011 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of NANOS 2011: Poster Presentations
Collection Neuro-Ophthalmology Virtual Education Library: NANOS Annual Meeting Collection: https://novel.utah.edu/collection/nanos-annual-meeting-collection/
Publisher North American Neuro-Ophthalmology Society
Holding Institution Spencer S. Eccles Health Sciences Library, University of Utah
Rights Management Copyright 2011. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s6fj5p98
Setname ehsl_novel_nam
ID 181798
Reference URL https://collections.lib.utah.edu/ark:/87278/s6fj5p98
Back to Search Results